Announcements Trials
Browse Landscape

Phase

Phase NA 27Phase 2 6Phase 3 3Phase 1 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Uterine Cervical Neoplasms 35Ovarian Neoplasms 31Endometrial Neoplasms 13Uterine Cervical Dysplasia 10Papillomavirus Infections 9Breast Neoplasms 9Uterine Neoplasms 7Ovarian Cysts 6Lung Neoplasms 6Stomach Neoplasms 4Neoplasms 4Esophageal Neoplasms 4Carcinoma, Ovarian Epithelial 4Polycystic Ovary Syndrome 3Ovarian Hyperstimulation Syndrome 3Liver Neoplasms 3Leiomyoma 3Head and Neck Neoplasms 3Carcinoma, Renal Cell 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Vomiting 2Uterine Diseases 2Urinary Bladder Neoplasms 2Tobacco Use Disorder 2Squamous Intraepithelial Lesions 2Small Cell Lung Carcinoma 2Recurrence 2Peritoneal Neoplasms 2Pancreatic Neoplasms 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Hereditary Breast and Ovarian Cancer Syndrome × Gynecologic × Clear all
NCT02562170 2015-09-29

Protexa® Versus TiLoopBra® in Immediate Breast Reconstruction- A Pilot Study

Medical University of Vienna

Phase 4 Completed
50 enrolled
BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡